Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature
Open Access
- 1 July 2001
- journal article
- review article
- Published by BMJ in Archives of Disease in Childhood: Fetal & Neonatal
- Vol. 85 (1), 18F-22
- https://doi.org/10.1136/fn.85.1.f18
Abstract
BACKGROUND Thrombosis is a relatively rare event in children. However, many conditions in the neonatal period result in an increased risk of thrombus formation. The major risk factor is the indwelling intravascular catheter. Numerous small studies have reported experience of thrombolytic treatment for neonatal thrombotic disease with a wide range of different thrombolytic agents in various forms of administration, dosage, and duration, but no conclusions on the most effective treatment for neonates has been reached. OBJECTIVE To assess the efficacy and safety of thrombolytic treatment of neonatal catheter related thrombus (CRT) formation with recombinant tissue plasminogen activator (rt-PA). METHOD Over a six year period, 14 neonates with CRT were treated with the same rt-PA protocol (an initial bolus of 0.7 mg/kg over 30–60 minutes followed by infusion of 0.2 mg/kg/h). RESULTS Complete clot dissolution was documented in 11 patients, and partial clot lysis in two patients, leading to a patency rate of 94%. In two cases, local bleeding occurred, resulting in treatment failure in one case. Finally, antithrombin III substitution was required in one case. No other complications such as severe bleeding were recognised. CONCLUSION With the use of close clinical and haematological monitoring on a neonatal intensive care unit combined with serial two dimensional colour echocardiography, the present rt-PA protocol was shown to be a safe and effective method of clot dissolution in neonates.Keywords
This publication has 42 references indexed in Scilit:
- Intraarterial Catheter-Directed Thrombolysis: Urokinase Versus Tissue Plasminogen ActivatorAnnals of Vascular Surgery, 1999
- Thrombolysis in Newborns and InfantsThrombosis and Haemostasis, 1999
- Tissue plasminogen activator for the treatment of thromboembolism in infants and childrenThe Journal of Pediatrics, 1991
- Diagnosis and management of thromboses in the perinatal period.1990
- Successful treatment of neonatal aortic thrombosis with tissue plasminogen activatorThe Journal of Pediatrics, 1990
- Investigational Use of Tissue Plasminogen Activator (t‐PA) for Occluded Central Venous CathetersJournal of Parenteral and Enteral Nutrition, 1990
- Plasminogen Activators: Pharmacology and TherapyRadiology, 1990
- Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy.1989
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- Venous Thromboembolism and Other Venous Disease in the Tecumseh Community Health StudyCirculation, 1973